Clinical Trial Update: Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating raltegravir with lamivudine/abacavir in HIV infection co-infected with tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Epivir (Lamivudine)
• Isentress (Raltegravir)
• Ziagen (Abacavir)

Snippet

Sponsor: Central Institute of Epidemiology, Moscow, Russia | Conditions: HIV Infections, Tuberculosis | Phase 4 | Status: COMPLETED